Page 24 - AIDSBK23C
P. 24

Page 24


               retention.  Additional problems include back pain, constipation, sexual dysfunction, and lower
               extremity sensory symptoms.  The microscopic pathologic findings include chronic
               meningomyelitis of white and grey matter with subsequent axonal degeneration that
               preferentially affects the lower thoracic cord. There is perivascular and parenchymal infiltration
               of T lymphocytes.  Lesions become less cellular and more atrophic later in the course of the
               disease.[110]
                       Laboratory findings with HTLV-1 include atypical lymphocytes seen on peripheral blood
               films, hypergammaglobulinemia, and a false positive VDRL.  Examination of CSF may reveal a
               mild lymphocyte pleocytosis, a mild to moderately increased protein, and oligoclonal bands.
               These findings usually are present in the first few years of disease, but they can persist as long as
               10 years after symptom onset.  HTLV-1 antibodies are found in the CSF, with higher titers in
               symptomatic persons.  TheHTLV-1 provirus can be demonstrated in the CSF of HAM/TSP
               patients by PCR.  Men are more likely to develop ATLL, while HAM/TSP is more common in
               women.[110]
                       HTLV-2 was initially identified as an endemic infection in two distinct populations:
               native peoples of the New World and pygmy tribes of Africa.  However, most infections now
               occur as a result of injection drug use, particularly in metropolitan areas of Europe, the U.S.,
               South America, and Asia.  There is no clear association between HTLV-2 and ATLL.  Chronic
               neurologic disease linked to HTLV-2 infection may include tropical spastic paraparesis,
               progressive spastic myelopathy, spastic ataxia, spinocerebellar syndrome, and chronic
               progressive neurologic disease.[111,112]
                       HTLV-3 and HTLV-4 agents have been identified in African populations.  These agents
               belong to the primate T lymphotropic virus group (PTLV).  HTLV-1/2 commercial tests are used
               for the detection of HTLV-3 and 4.  Few cases have been discovered.  The long latency of HTLV
               will mean that decades can pass before the modes of transmission and pathologic effects become
               characterized fully.[113]
   19   20   21   22   23   24   25   26   27   28   29